The "Clinical Progress Conference on Interstitial Lung Disease" was successfully held in Chengdu from July 25 to 26,2025. Organized by the Chengdu High-Tech Medical Association and hosted by its Interstitial Lung Disease Committee, the event brought together respiratory medicine specialists, rheumatology immunologists, radiologists, and pathologists from across China. Participants engaged in in-depth discussions on cutting-edge research, innovative diagnostic techniques, and clinical practices in the field of Interstitial Lung Disease (ILD). This initiative aims to enhance China's diagnostic and therapeutic capabilities for ILD and provide greater hope for patients worldwide.
01 Opening ceremony address
Professor Kim Hong
West China Hospital, Sichuan University
Director, Interstitial Lung Disease Committee
Professor Jin Hong first extended his warmest welcome and sincere gratitude to all experts, scholars, and healthcare professionals attending the conference. The event featured a meticulously curated academic program across five key areas: Imaging, Therapeutics, Exploration, Comprehensive Studies, and Clinical Case Analysis. Distinguished experts with pioneering achievements in ILD diagnosis and treatment were invited to deliver keynote lectures, providing in-depth interpretations of cutting-edge research findings and clinical practices. Interactive sessions including case discussions and academic exchanges were also organized to foster open dialogue and spark intellectual exchanges. Professor Jin emphasized that through these collaborative dialogues, we can strengthen consensus-building, enhance multidisciplinary cooperation, and continuously advance clinical research and treatment standards for interstitial lung diseases. "Let us work together to bring greater hope and well-being to ILD patients," he concluded. He wished the conference a resounding success and expressed his best wishes for the health and professional success of all attending experts and colleagues.
Professor Ehrhe
Vice President and Deputy Secretary-General of Chengdu High-tech Medical Association
Vice President Ai He extended a warm welcome and heartfelt gratitude on behalf of the Chengdu High-Tech Medical Association to all experts and colleagues attending this conference. The event has been honored to gather top-tier specialists and outstanding clinical practitioners from across China. With their rich experience and cutting-edge research achievements, these distinguished participants have assembled here for a rare academic feast that offers a precious opportunity for collective advancement. We hope this conference will facilitate in-depth exchanges on the latest developments in interstitial lung diseases, enable knowledge sharing, and foster innovative approaches to disciplinary progress. Together, we aim to contribute wisdom and strength to elevate diagnostic and therapeutic standards for these conditions. Finally, we wish this conference a resounding success!
02 Lecturer profile
Chen Qi-hang
Beijing Hospital
Zhao Shaohong
General Hospital of the Chinese People's Liberation Army
Wang Rengui
Beijing Shijitan Hospital affiliated to Capital Medical University
Kingsong
West China Hospital, Sichuan University
Li Heping
Shanghai Chest Hospital affiliated to Tongji University
Ren Tao
Shanghai Sixth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine
Xu Kaifeng
Peking Union Medical College Hospital
Feng Rui-e
Peking Union Medical College Hospital
Liu Xiaolei
Geriatric Medicine Center, West China Hospital, Sichuan University
Cai Horong
Gulou Hospital affiliated to Nanjing Medical University
Ye Qiao
Beijing Chaoyang Hospital affiliated to Capital Medical University
Summary of the 03 meeting
Professor Kim Hong
West China Hospital, Sichuan University
Director, Interstitial Lung Disease Committee
Professor Jin Hong extended heartfelt gratitude to all distinguished guests, scholars attending the conference from afar, and the dedicated team members who contributed to its success. The successful hosting of this "Interstitial Lung Disease Clinical Progress Conference" has established a premier academic platform for Chinese experts, scholars, and healthcare professionals in the field of Interstitial Lung Disease (ILD). Through in-depth discussions on cutting-edge research findings, sharing of latest diagnostic techniques, and exchange of clinical experience, the event significantly enhanced the medical community's comprehensive understanding of ILD and substantially advanced China's diagnostic and therapeutic capabilities in this area. With collaborative efforts from all stakeholders, we are confident that new breakthroughs will continue to emerge in ILD diagnosis and treatment, bringing greater hope to patients worldwide.
The closing ceremony is not the end, but a new starting point. We look forward to continuous communication in the future, transforming the achievements of this conference into driving force for the development of ILD, and making joint contributions to ILD.
